VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
TSX:VHI - Toronto Stock Exchange - CA92847V5018 - Common Stock - Currency: CAD
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 6 industry peers in the Health Care Technology industry. VHI has an excellent financial health rating, but there are some minor concerns on its profitability. VHI is growing strongly while it is still valued neutral. This is a good combination! These ratings could make VHI a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
In the past year VHI had a positive cash flow from operations.
In multiple years VHI reported negative net income over the last 5 years.
In multiple years VHI reported negative operating cash flow during the last 5 years.
1.2 Ratios
VHI has a Return On Assets of 1.77%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.35%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI had an Average Return On Invested Capital over the past 3 years of 2.92%. This is in line with the industry average of 4.35%.
The last Return On Invested Capital (4.35%) for VHI is above the 3 year average (2.92%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.77% | ||
| ROE | N/A | ||
| ROIC | 4.35% |
ROA(3y)0.77%
ROA(5y)-0.73%
ROE(3y)1.2%
ROE(5y)-0.89%
ROIC(3y)2.92%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 5.11%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI has a better Operating Margin (13.54%) than 100.00% of its industry peers.
VHI's Gross Margin of 81.13% is amongst the best of the industry. VHI outperforms 83.33% of its industry peers.
VHI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.54% | ||
| PM (TTM) | 5.11% | ||
| GM | 81.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y-0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
VHI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
VHI has an Altman-Z score of 3.26. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
VHI has a better Altman-Z score (3.26) than 83.33% of its industry peers.
VHI has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
The Debt to FCF ratio of VHI (0.02) is better than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 0.02 | ||
| Altman-Z | 3.26 |
ROIC/WACC0.45
WACC9.64%
2.3 Liquidity
VHI has a Current Ratio of 2.33. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.33, VHI belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
VHI has a Quick Ratio of 2.33. This indicates that VHI is financially healthy and has no problem in meeting its short term obligations.
VHI has a Quick ratio of 2.33. This is amongst the best in the industry. VHI outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.33 | ||
| Quick Ratio | 2.33 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.50%.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 22.74%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 41.94% on average per year.
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)22.74%
Revenue growth 3Y56.14%
Revenue growth 5Y41.94%
Sales Q2Q%24.84%
3.2 Future
The Earnings Per Share is expected to grow by 40.70% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 20.73% on average over the next years. This is a very strong growth
EPS Next Y-31.14%
EPS Next 2Y43.73%
EPS Next 3Y40.7%
EPS Next 5YN/A
Revenue Next Year28.59%
Revenue Next 2Y28.12%
Revenue Next 3Y20.73%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 130.00 indicates a quite expensive valuation of VHI.
Compared to the rest of the industry, the Price/Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
VHI is valuated expensively when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 40.04, which means the current valuation is very expensive for VHI.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
VHI is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 130 | ||
| Fwd PE | 40.04 |
4.2 Price Multiples
VHI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VHI is cheaper than 83.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.93 | ||
| EV/EBITDA | 31.39 |
4.3 Compensation for Growth
VHI has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 40.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.73%
EPS Next 3Y40.7%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (3/7/2025, 7:00:00 PM)
9.1
-0.1 (-1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners30.84%
Inst Owner ChangeN/A
Ins Owners12.77%
Ins Owner ChangeN/A
Market Cap507.60M
Analysts81.82
Price Target13.77 (51.32%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.1%
Min EPS beat(2)-130.46%
Max EPS beat(2)-25.74%
EPS beat(4)0
Avg EPS beat(4)-55.26%
Min EPS beat(4)-130.46%
Max EPS beat(4)-25.74%
EPS beat(8)1
Avg EPS beat(8)-39.47%
EPS beat(12)2
Avg EPS beat(12)-52.5%
EPS beat(16)2
Avg EPS beat(16)-119.85%
Revenue beat(2)1
Avg Revenue beat(2)1.43%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)3.7%
Revenue beat(4)2
Avg Revenue beat(4)2%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)5.76%
Revenue beat(8)6
Avg Revenue beat(8)2.93%
Revenue beat(12)8
Avg Revenue beat(12)3.45%
Revenue beat(16)11
Avg Revenue beat(16)2.96%
PT rev (1m)0.62%
PT rev (3m)1.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)1.35%
EPS NY rev (3m)-3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 130 | ||
| Fwd PE | 40.04 | ||
| P/S | 8.24 | ||
| P/FCF | 23.93 | ||
| P/OCF | 23.4 | ||
| P/B | 10.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 31.39 |
EPS(TTM)0.07
EY0.77%
EPS(NY)0.23
Fwd EY2.5%
FCF(TTM)0.38
FCFY4.18%
OCF(TTM)0.39
OCFY4.27%
SpS1.1
BVpS0.89
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.77% | ||
| ROE | N/A | ||
| ROCE | 6.05% | ||
| ROIC | 4.35% | ||
| ROICexc | 10.63% | ||
| ROICexgc | N/A | ||
| OM | 13.54% | ||
| PM (TTM) | 5.11% | ||
| GM | 81.13% | ||
| FCFM | 34.43% |
ROA(3y)0.77%
ROA(5y)-0.73%
ROE(3y)1.2%
ROE(5y)-0.89%
ROIC(3y)2.92%
ROIC(5y)N/A
ROICexc(3y)4.26%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.06%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y-0.28%
F-Score5
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 0.02 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 9.27% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 159.7% | ||
| Profit Quality | 673.22% | ||
| Current Ratio | 2.33 | ||
| Quick Ratio | 2.33 | ||
| Altman-Z | 3.26 |
F-Score5
WACC9.64%
ROIC/WACC0.45
Cap/Depr(3y)7.72%
Cap/Depr(5y)6.54%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-31.14%
EPS Next 2Y43.73%
EPS Next 3Y40.7%
EPS Next 5YN/A
Revenue 1Y (TTM)22.74%
Revenue growth 3Y56.14%
Revenue growth 5Y41.94%
Sales Q2Q%24.84%
Revenue Next Year28.59%
Revenue Next 2Y28.12%
Revenue Next 3Y20.73%
Revenue Next 5YN/A
EBIT growth 1Y76.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year63.95%
EBIT Next 3Y38.92%
EBIT Next 5YN/A
FCF growth 1Y187.07%
FCF growth 3Y309.46%
FCF growth 5YN/A
OCF growth 1Y186.44%
OCF growth 3Y269.75%
OCF growth 5YN/A